Editas Medicine, Inc. (EDIT)

Editas Medicine Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	69.41	78.12	19.71	25.54	90.73	20.53
Revenue Growth (YoY)	204.54%	296.32%	-22.83%	-71.85%	341.93%	-35.71%
Gross Profit	69.41	78.12	19.71	25.54	90.73	20.53
Selling, General & Admin	65.98	69.65	70.7	76.18	67.58	64.56
Research & Development	188.63	177.65	174.96	142.51	158	96.9
Operating Expenses	254.62	247.3	245.66	218.69	225.57	161.45
Operating Income	-185.21	-169.18	-225.95	-193.15	-134.84	-140.92
Interest Expense / Income	-19.09	-17.57	-5.52	-0.61	-2.61	-7.31
Other Expense / Income	0.02	1.6	-	-0.04	-16.26	0.14
Pretax Income	-166.13	-153.22	-220.43	-192.5	-115.98	-133.75
Net Income	-166.13	-153.22	-220.43	-192.5	-115.98	-133.75
Shares Outstanding (Basic)	82	76	69	68	59	50
Shares Outstanding (Diluted)	82	76	69	68	59	50
Shares Change	18.88%	10.63%	1.55%	15.37%	17.26%	6.13%
EPS (Basic)	-2.08	-2.02	-3.21	-2.85	-1.98	-2.68
EPS (Diluted)	-2.08	-2.02	-3.21	-2.85	-1.98	-2.68
Free Cash Flow	-151.03	-136.9	-181.45	-171.78	-186.99	-46.73
Free Cash Flow Per Share	-1.84	-1.80	-2.64	-2.54	-3.19	-0.94
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-266.85%	-216.56%	-1146.26%	-756.13%	-148.61%	-686.39%
Profit Margin	-239.36%	-196.13%	-1118.26%	-753.61%	-127.82%	-651.43%
Free Cash Flow Margin	-217.60%	-175.23%	-920.50%	-672.49%	-206.09%	-227.63%
EBITDA	-179.3	-164.72	-219.61	-188.06	-114.62	-138.23
EBITDA Margin	-258.33%	-210.85%	-1114.11%	-736.20%	-126.33%	-673.27%
Depreciation & Amortization	5.93	6.06	6.34	5.05	3.96	2.83
EBIT	-185.23	-170.79	-225.95	-193.11	-118.58	-141.06
EBIT Margin	-266.87%	-218.61%	-1146.26%	-755.99%	-130.69%	-687.05%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).